Related Experiment Videos
Dissolution improvement of high drug-loaded solid dispersion.
Siriporn Okonogi1, Satit Puttipipatkhachorn
1Faculty of Pharmacy, Department of Pharmaceutical Sciences, Chiang Mai University, Chiang Mai, 50200, Thailand. sirioko@chiangmai.ac.th
AAPS Pharmscitech
|June 27, 2006
Summary
This study enhanced ofloxacin dissolution using ternary solid dispersions with polyethylene glycol and polysorbate 80. The surfactant improved drug wettability and solubility, significantly boosting dissolution rates.
Area of Science:
- Pharmaceutical Sciences
- Materials Science
Background:
- Water-insoluble drugs often exhibit poor bioavailability.
- Solid dispersion technology can enhance drug solubility and dissolution.
- Ofloxacin (OFX) is a water-insoluble antibiotic requiring formulation improvements.
Purpose of the Study:
- To investigate the effect of a nonionic surfactant, polysorbate 80, on the dissolution of high drug-loaded ofloxacin solid dispersions.
- To compare the performance of binary (drug-carrier) and ternary (drug-carrier-surfactant) solid dispersion systems.
Main Methods:
- Preparation of binary solid dispersions of ofloxacin (OFX) with polyethylene glycol (PEG) of varying molecular weights.
- Incorporation of polysorbate 80 to form ternary solid dispersion systems.
- Characterization using powder X-ray diffraction (PXRD) and differential scanning calorimetry (DSC).
- In vitro dissolution testing to assess drug release.
Main Results:
- Powder XRD and DSC confirmed the presence of crystalline and amorphous ofloxacin in the solid dispersions.
- Ternary solid dispersion systems exhibited significantly improved drug dissolution compared to binary systems.
- Polysorbate 80 enhanced the wettability and solubilization of ofloxacin.
Conclusions:
- Ternary solid dispersions containing polysorbate 80 are effective in enhancing the dissolution of water-insoluble ofloxacin.
- Polysorbate 80 plays a crucial role in improving drug release by enhancing wettability and solubilization.
- This formulation strategy holds promise for improving the bioavailability of poorly soluble drugs.